|
|
A person with
Alzheimer's disease (AD) needs some help every day. In the early stages of the
disease, the help needed may consist of little reminders of people's names or
recent events, some hints about finding lost or misplaced objects, and support
for daily tasks like paying bills or doing routine chores. As time goes on, the
person with AD may need more assistance with basic day-to-day activities such as
dressing, bathing, or grooming. Those who care
for someone with AD--the "caregivers"--often need help, too. In the
beginning, there are questions about the disease and its Help Is There When You Need It... One of the most important things to know is that you are not alone. Eisai Inc. and Pfizer Inc, in collaboration with the Alzheimer's Association and The National Council on the Aging, sponsor a support program called TriAD™. The program's name stands for the three people involved whenever someone has AD: the healthcare professional, the person with AD, and the caregiver. TriAD™ provides help to all three. What TriAD
Can
Do for Those First of all, TriAD™
provides information.
Brochures like Learning About Alzheimer's Disease and Living With
Alzheimer's Disease are written for the Secondly, TriAD™
offers support. Every other month, as long as you are enrolled in the TriAD™program, you will receive a
newsletter full of helpful suggestions about living day-to-day with AD, stories
about how people just like you are coping, what is new in the field of AD
research, how to rake care of yourself during times of stress, and how to
simplify daily tasks. And the editors of these newsletters want to hear from
you, too. In every issue, there is space to record your feedback and an easy way
to send it in if you would like. When you learn that there are thousands of
people in the TriAD™program who
share your challenges, and that you can communicate with them in the pages of
the newsletter, you are less likely to feel alone. Finally, TriAD™ links you with services you need. Just one phone call to a toll-free number (1-888-TriADHELP) can tell you what resources are available in your own community...where to find legal or financial planning services specifically for persons with AD...what you should know about Medicare and Medicaid...the location of the nearest adult day services center or respite service...and about other services helpful to persons with AD. It is especially important for caregivers to learn where to meet face-to-face with other people providing daily care; for example, in a support group such as the local Alzheimer's Association Chapter. Local support groups like these and others may help you avoid feeling overwhelmed or depressed, feelings which are common in caregivers of people with AD. The TriAD™ Helpline (1-888-TriADHELP) can provide information on finding such a group. How
to Become Part of the TriAD Program... Only
a healthcare professional can enroll you in TriAD™.
If you picked up this brochure in the waiting room of your healthcare professional,
ask him or her to enroll you. If you found the brochure on the counter at your
pharmacy, or at your Alzheimer's Association support group, bring it to your
healthcare professional and ask for a TriAD™
Enrollment Kit. TriADTM is intended to provide general guidance based on currently available information. It does not, however, provide individuals with medical, financial, or legal advice. A competent professional should be consulted for specific advice in any of these areas. References: 1. Caregiver network helps temper significant hardships in
laboring for Alzheimer's relatives. Primary Psychiatry. November
1996;2(pt 1 ):20,21,92.2. Mittelman MS, Ferris SH, Shulman E, et al. A
comprehensive support program: effect on depression in spouse-caregivers of AD
patients. Gerontologist. 1995;35:792-802.3. Brodaty H, McGilchrist C,
Harris L, Peters KE. Time until institutionalization and death in patients with
dementia. Arch Neurol. 1993;50:643-650.4. Mittelman MS, Ferris SH,
Shulman E, Steinberg G, Levin B. A family intervention to delay nursing home
placement of patients with Alzheimer disease: a randomized controlled trial.
JAMA. 1996;276:1725-1731.
|